Bixiye
QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Natiijooyinka Raadinta
Soo bandhiga 2261 - 2270 ee natiijooyinka 4296
Bixiye
QP57-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization Criteria: tafamidis
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP49-19 Pharmacy Benefit Exclusion for Proventil (albuterol sulfate) HFA and Proventil (albuterol sulfate) HFA Authorized Generic (AG)
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP54-19 Pharmacy Benefit Update – New Drug-Related Utilization Management Program: Opioid Immediate Release (IR) New to Therapy (NTT) Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP52-19 Pharmacy Benefit Exclusion for Cimzia, Elzonris, Gamifant, Kalbitor, Khapzory, leucovorin calcium, Nuzyra and Panzyga
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP53-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Neurotrophic Keratitis
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP59-19 eviCore Group Number List to be Removed
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP51-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Firdapse
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP45-19 Providers Need to Validate Members Coverage
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP55-19 Authorization Attachment Tips on Availity Provider Portal
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019